Literature DB >> 22362342

Potentially inappropriate medications in the elderly: a comprehensive protocol.

Suzana Mimica Matanović1, Vera Vlahovic-Palcevski.   

Abstract

Elderly patients are at increased risk of drug-related morbidity and mortality. Avoiding the use of potentially inappropriate medications (PIMs) is one of the strategies that has been widely adopted to reduce the harmful consequences of drug use. There are several PIM screening tools available. In this review, we provide an overview of existing screening tools to detect PIMs in the elderly, emphasizing the advantages and disadvantages of each. Combining previously published and adopted tools (adjusted Beers list, French consensus panel, McLeod's list, and Lindblad's list of clinically important drug-disease interactions), we develop a new comprehensive tool that also includes the adjusted Hanlon's and Malone's lists of potentially serious drug-drug interactions in the elderly. In addition to listed PIMs and clinically important drug-drug interactions, alternative therapeutic solutions are suggested. The new protocol differentiates: drugs with an unfavorable benefit/risk ratio (to be avoided regardless of the underlying disease/condition), drugs with a questionable efficacy, and drugs to be avoided with certain diseases/conditions, and provides a list of potentially serious drug-drug interactions. A tool consisting of PIMs and potential drug-drug interactions within the same protocol provides more comprehensive quality assessment of drug-prescribing behavior to the elderly, which in turn may lead to better prescribing practices.

Entities:  

Mesh:

Year:  2012        PMID: 22362342     DOI: 10.1007/s00228-012-1238-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  72 in total

1.  Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly.

Authors:  Graziano Onder; Francesco Landi; Matteo Cesari; Giovanni Gambassi; Pierugo Carbonin; Roberto Bernabei
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953

2.  The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.

Authors:  Paula T Einhorn; Barry R Davis; Barry M Massie; William C Cushman; Linda B Piller; Lara M Simpson; Daniel Levy; Chuke E Nwachuku; Henry R Black
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

Review 3.  EPS profiles: the atypical antipsychotics are not all the same.

Authors:  Peter J Weiden
Journal:  J Psychiatr Pract       Date:  2007-01       Impact factor: 1.325

Review 4.  [Possibilities and limits of therapy of cognition disorders in the elderly].

Authors:  S Hoyer
Journal:  Z Gerontol Geriatr       Date:  1995 Nov-Dec       Impact factor: 1.281

Review 5.  Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

Authors:  J M Siller-Matula; B Jilma; K Schrör; G Christ; K Huber
Journal:  J Thromb Haemost       Date:  2010-12       Impact factor: 5.824

Review 6.  Proton pump inhibitor and clopidogrel interaction: fact or fiction?

Authors:  Loren Laine; Charles Hennekens
Journal:  Am J Gastroenterol       Date:  2009-11-10       Impact factor: 10.864

7.  STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria.

Authors:  Paul Gallagher; Denis O'Mahony
Journal:  Age Ageing       Date:  2008-10-01       Impact factor: 10.668

8.  Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.

Authors:  Marilisa Franceschi; Carlo Scarcelli; Valeria Niro; Davide Seripa; Anna Maria Pazienza; Giovanni Pepe; Anna Maria Colusso; Luigi Pacilli; Alberto Pilotto
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.

Authors:  Alex Z Fu; Jenny Z Jiang; Jaxk H Reeves; Jack E Fincham; Gordon G Liu; Matthew Perri
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

10.  The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study.

Authors:  Sture Rognstad; Mette Brekke; Arne Fetveit; Olav Spigset; Torgeir Bruun Wyller; Jørund Straand
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

View more
  12 in total

1.  Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol.

Authors:  Iva Mucalo; Maja Ortner Hadžiabdić; Andrea Brajković; Sonja Lukić; Patricia Marić; Ivana Marinović; Vesna Bačić-Vrca
Journal:  Eur J Clin Pharmacol       Date:  2017-04-12       Impact factor: 2.953

2.  Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs.

Authors:  Suzana Mimica Matanović; Vera Vlahović-Palčevski
Journal:  Eur J Clin Pharmacol       Date:  2014-01-24       Impact factor: 2.953

Review 3.  Inappropriate prescribing: a systematic overview of published assessment tools.

Authors:  Carole P Kaufmann; Regina Tremp; Kurt E Hersberger; Markus L Lampert
Journal:  Eur J Clin Pharmacol       Date:  2013-09-10       Impact factor: 2.953

Review 4.  Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review.

Authors:  Nashwa Masnoon; Sepehr Shakib; Lisa Kalisch-Ellett; Gillian E Caughey
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

5.  Inclusion of Potentially Inappropriate Medicines for the Older Adults in the Brazilian Consensus in Accordance with International Criteria.

Authors:  Andréa Pecce Bento; Leonardo Costa Pereira; Kerolyn Ramos Garcia; Luiz Fernando Ramos Ferreira; Emília Vitória da Silva; Margô Karnikowski
Journal:  Clin Interv Aging       Date:  2022-02-16       Impact factor: 4.458

6.  Impact of Drug-Drug and Drug-Disease Interactions on Gait Speed in Community-Dwelling Older Adults.

Authors:  Jennifer G Naples; Zachary A Marcum; Subashan Perera; Anne B Newman; Susan L Greenspan; Shelly L Gray; Douglas C Bauer; Eleanor M Simonsick; Ronald I Shorr; Joseph T Hanlon
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

Review 7.  Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.

Authors:  Eline Tommelein; Els Mehuys; Mirko Petrovic; Annemie Somers; Pieter Colin; Koen Boussery
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

8.  Potentially inappropriate prescribing in elderly outpatients in Croatia.

Authors:  Branislava Popović; Nives Radošević Quadranti; Suzana Mimica Matanović; Ines Diminić Lisica; Aleksandar Ljubotina; Dubravka Pezelj Duliba; Vera Vlahović-Palčevski
Journal:  Eur J Clin Pharmacol       Date:  2014-03-21       Impact factor: 2.953

9.  Myoclonus in renal failure: Two cases of gabapentin toxicity.

Authors:  Kenneth R Kaufman; Amay Parikh; Lili Chan; Mary Bridgeman; Milisha Shah
Journal:  Epilepsy Behav Case Rep       Date:  2013-12-29

10.  International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy.

Authors:  Jean-Baptiste Beuscart; Wilma Knol; Shane Cullinan; Claudio Schneider; Olivia Dalleur; Benoit Boland; Stefanie Thevelin; Paul A F Jansen; Denis O'Mahony; Nicolas Rodondi; Anne Spinewine
Journal:  BMC Med       Date:  2018-02-13       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.